Ardelyx (NASDAQ:ARDX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks, “Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and Ardelyx (NASDAQ:ARDX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, Zacks.com reports. The firm currently has a $8.75 target price on the biopharmaceutical company’s stock. Zacks Investment Research‘s price target suggests a potential upside of 14.08% from the stock’s previous […] Zacks Investment Research cut shares of Ardelyx (NASDAQ:ARDX) from a buy rating to a hold rating in a report published on Tuesday, Zacks.com reports. According to Zacks, “Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. Ardelyx (NASDAQ:ARDX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI
ARDX: Ardelyx Inc Detailed Estimate. Get the latest Detailed Estimate from Zacks Investment Research. The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style. We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating: 新浪财经-美股频道为您提供ardx(ardx)股票股价,股票实时行情,新闻,财报,美股实时交易数据,研究报告,评级,财务指标分析等与ardx(ardx)股票相关的信息与服务
Summer Infant Inc. - MarketWatch Summer Infant, Inc. (SUMR) CEO Stuart Noyes on Q1 2020 Results - Earnings Call Transcript May. 13, 2020 at 12:27 p.m. ET on Seeking Alpha 10-Q: SUMMER INFANT, INC. Broadcom Inc. Common Stock (AVGO) Earnings Report Date ...
MITTS linked to S&P 500 Index 2014) MGK (领航 超大盘股票成长型 ETF) MGPI (MGP Ingredients Inc.) MGR (Affiliated Managers Group Inc.) MGU (麦格理全球投资) MGV (Vanguard Mega Cap Value ETF) MHD (黑岩合作债务基金) MHF (Western Asset Municipal High Income Fund Inc.) MHH (Mastech Digital Inc.) MHI (先锋市政债务) MHK ARDX Ardelyx traded down $-0.16 at close of the trading on Wednesday, hitting $7.89 daily high and touching the bottom line at 7.12. The company had a trading volume of 495279 shares, compared to its average volume of 712817. The company has a BETA of 1.89. ARDX Ardelyx has a 12-month low of $2.1 and a 12-month high of $8.82.
Should I buy Ardelyx, Inc. (ARDX)? Use the Zacks Rank and Style Scores to find out is ARDX is right for your portfolio. Ardelyz Appoints Justin Renz As CFO Ardelyx Inc (NASDAQ: ARDX) announced the appointment of biopharma industry veteran Justin Renz Zacks•2 days ago